Minerva Neurosciences reported $-8718000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
ALKERMES ALKS:US $ -30.14M 5.77M
AstraZeneca AZN:LN 360M 26M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Bristol Myers Squibb BMY:US $ 1421M 143M
Dynavax Technologies DVAX:US $ 128.76M 95.9M
Eli Lilly And LLY:US $ 952.5M 950.4M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
GlaxoSmithKline GSK:LN 838M 964M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Johnson & Johnson JNJ:US $ 4814M 335M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Merk MRK:US $ 3944M 366M
Minerva Neurosciences NERV:US $ -8.72M 1.05M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Takeda 4502:JP Y 105014M 116372M